Navigation Links
Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
Date:3/8/2012

BERN, Switzerland, March 8, 2012 /PRNewswire/ --

  • Quality of Life (QoL) is strongly diminished in RVVC patients
  • Current available treatment fails in two thirds of patients
  • High medical need demands novel effective treatment options

Pevion Biotech AG today announced results from a large, international survey on the Quality of Life (QoL) of recurrent vulvovaginal candidiasis (RVVC) patients. It is the first time that the overall disease burden of RVVC has been quantified by validated tools, thereby showing that QoL is strongly diminished and that RVVC has a significant impact on patients' daily activities and productivity. The survey furthermore confirmed previous findings that current use of antifungal drugs is inadequate and that it presents a therapeutic failure in more than two thirds of the RVVC patients.

"This study not only highlights the heavy burden associated with the disease, but also the very high unmet medical need," said Professor Mondher Toumi, Chair of Market Access at the University of Lyon 1, France. "The lack of effectiveness and constraint related to chronic treatment are a source of low compliance because there is low perceived benefit with current treatment. Based on cost per quality-adjusted life year (QALY) the society appears ready to pay a high price for an effective intervention in that indication."

"Pevion recently announced the outcome of the largest epidemiological survey ever performed regarding RVVC, confirming that 7% of all adult women suffer from this disease," commented Evert Kueppers, Pevion's Chief Executive Officer. "The outcome of this Quality of Life study confirms that RVVC not only is wide spread, but that it also has a significant impact on the lives of millions of women suffering from RVVC. Presently, RVVC is an under-recognized public health problem affecting mostly young and active parts of the society."

Recurrent vulvova
'/>"/>

SOURCE Pevion Biotech AG
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pevion Biotech Appoints New CEO and Secures CHF 10 Million Financing
2. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
3. Pevion Grants CSL Option Right to its Therapeutic Candida Vaccine
4. Pevions Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
(Date:5/17/2013)... Sinovac Biotech Ltd. (Nasdaq: SVA ), ... , today announced that it will release its unaudited financial ... market on Tuesday, May 28, 2013.  The Company will host ... a.m. EDT (May 28, 2013 at 8:00 p.m. China Standard ... update on recent corporate developments. To access the ...
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... , LISBON, Portugal, September 11 ... Confirms Superiority of the New Intranasal Treatment,for Breakthrough Cancer Pain ... today further demonstrate the efficacy of Instanyl in,management of breakthrough ... of the European Federation of Chapters of the International,Association for ...
... , THOUSAND OAKS, Calif., Sept. 10 ... new data will be presented on the burden of osteoporosis, ... American Society for Bone and Mineral Research (ASBMR) annual meeting ... being evaluated by regulatory bodies in the United States (U.S.), ...
Cached Medicine Technology:Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 3Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 2Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 3Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 5Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 6Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 7Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 8
(Date:5/18/2013)... Pomona, NY (PRWEB) May 18, 2013 Dr. ... sleep apnea dentistry, employs his knowledge of the ... in sleep apnea patients. With May being Better Sleep Month, ... have some sort of chronic sleep disorder, and sleep apnea ... With sleep apnea, a person will essentially stop breathing at ...
(Date:5/18/2013)... The topics that will be covered in the 1-day Agile ... scrum artifacts, and scrum simulation (optional). One can earn eight ... trainings are suitable for business analysts, project managers, developers, testers, ... be a part of the Scrum team, people outside the ... Scrum, but are unsure of what it is. , ...
(Date:5/18/2013)... Kimono condoms assorted sampler packs ... recently announced. Condomania recently added new Kimono condoms ... condoms from all over the world. The new ... different condom styles from one of the most popular ... shape and secure, the new packs contain something for ...
(Date:5/18/2013)... Provo, UT (PRWEB) May 18, 2013 Medical ... pre-launch orders for its much anticipated mobility aid with its ... to create a hands-free crutch alternative that injured ... a broken ankle, for example, can remain active and walk ... team is using its reservation system to ensure those who ...
(Date:5/18/2013)... OH (PRWEB) May 18, 2013 The product ... Skechers lawsuits on behalf of consumers nationwide who have ... of Shape-Ups toning shoes. These cases are all part of ... These Skechers lawsuits will be heard in the ... Division. , Wright & Schulte, LLC specializes in defending ...
Breaking Medicine News(10 mins):Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Kimono Condoms Assorted Sampler Packs Now Available at Condomania 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4
... Researchers in New York City say they are the first ... cells. A team at Albert Einstein College of Medicine ... gene transcription in living yeast cells, they say. Transcription occurs ... messenger RNA (mRNA) that then make the protein coded by ...
... , WEDNESDAY, April 27 (HealthDay News) -- Doctors are far ... for an expensive MRI scan if they own or lease ... University School of Medicine researchers also found that after orthopedists ... have back surgery within six months of seeing the orthopedist ...
... News) -- Reading a book can satisfy the crucial human ... research involved 140 university students who were given 30 minutes ... novel Twilight or the wizard novel Harry ... the lives of either vampires or wizards. The participants ...
... Society for Radiation Oncology (ASTRO) has developed a guideline ... brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused ... in Practical Radiation Oncology , an official journal ... receive radiation therapy to treat symptoms related to cancer, ...
... Edmonton Researchers in the Faculty of Medicine & Dentistry ... that provides a new understanding of how our immune system ... affect the way doctors treat patients with autoimmune diseases and ... part of experimental therapies to treat autoimmune diseases such as ...
... on a roadside and rushed to the University of Rochester Medical ... breakdown, doctors were surprised to discover that a trendy tea derived ... The URMC team reported the case study, believed to be the ... American Journal of Emergency Medicine . They described it ...
Cached Medicine News:Health News:Researchers Describe Gene Activity in Living Cells 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 3Health News:ASTRO publishes evidence-based guideline for thoracic radiotherapy 2Health News:Discovery could change the way doctors treat patients with cancer and autoimmune diseases 2Health News:Medical sleuthing linked muscle, kidney problems to kava tea 2Health News:Medical sleuthing linked muscle, kidney problems to kava tea 3
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
The CapSure Z Novus is an endocardial, tined, high-efficiency lead. High efficiency combined with steroid elution allows safe, low output programming....
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
Medicine Products: